Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial
Rajiv K. Pruthi, Prasad Mathew, Leonard A. Valentino, Michael J. Sumner, Stephanie Seremetis, W. Keith Hoots, M. Elaine Eyster, David Green, Anne Hurlet, Barbara Konkle, Cindy Leissinger, Jamie E. Siegel
Dive into the research topics of 'Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial'. Together they form a unique fingerprint.